Patient-centred care in psoriasis
Importance of people-centred care in psoriasis
The World Health Organization encourages a people-centred approach to care of people with chronic and complex conditions, including psoriasis1.
A people-centred approach involves providing healthcare and services in a way that responds to their preferences, are coordinated to their needs, and are safe, effective, timely, efficient and of acceptable quality1
Shifting to a people-centred approach may help to optimise treatment of psoriasis and management of comorbidities1. Use of a people-centred approach for management of psoriasis should start with assessing and considering the full spectrum of the person's needs, including psoriasis-related issues, and other issues concerning their health and wellbeing1.
- Patients should be listened to and heard, and given the time and space needed to voice their concerns and opinions2
- Patients should be given the opportunity to play an active role in decisions about their management, and be actively encouraged to engage in all aspects of their care2
Treatment goals based on patient perspectives and expectations
Accurate information about a patient’s needs can assist with selecting a treatment approach that best fits the profile of that patient, enabling a more personalised approach to treatment3
A cross-sectional survey of 1,200 people with psoriasis explored treatment goals that are important to patients, using the Patient Needs Questionnaire (PNQ) of Patient Benefit Index (PBI). Results of this study indicated the top five treatment goals in the overall study population were to3:
- have confidence in the therapy
- regain control of the disease
- have no fear that the disease will become worse
- get better skin quickly
- be free of itching
Results also indicated treatment preferences varied according to patient characteristics such as age, severity and gender3. In the higher severity subgroup, one of the top five goals was ‘‘to find a clear diagnosis and therapy’’, whereas ‘‘to get better skin quickly’’ was included in the top 5 goals of the lower severity subgroup3.
The authors proposed that further exploration of these data may help to inform treatment decisions and optimise patient outcomes3.
of interest
are looking at
saved
next event
Developed for Medthority by EPG Health. This content has been developed independently of the sponsors who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.